You are viewing just a glimpse of the 100+ pieces of sophisticated insight and analysis produced by our full-time team of senior financial journalists every day. For full access, check to see if your firm has a license to The Deal Pipeline or login using your existing credentials.
Know your ID?
Username:
 
Password:
Go

Subscriber Content Preview | Request a free trialSearch  
  Go

Healthcare

Genomma makes unsolicited bid for Prestige Brands

Mexican consumer products and drug company Genomma Lab Internacional SAB de CV on Tuesday, Feb. 21, unveiled an unsolicited $834 million offer for Prestige Brands Holdings Inc. in hopes of forcing its Irvington, N.Y.-based rival to the negotiating table.Genomma, of... Continue reading

Stromedix and Biogen, the backstory

When Michael Gilman left his post in 2005 as the executive vice president of research at Biogen Idec Inc. -- a post he'd manned for five years -- he had no idea that a piece of that business would ultimately... Continue reading

Social networking startup offers online corporate dating

The Miami-based provider seeks to match middle market buyers, sellers and intermediaries for a fee. Continue reading

Peninsula Hospital unsecureds win co-exclusivity

Peninsula Hospital Center now could have two reorganization plans. Continue reading

Biogen buys Stromedix

The deal for the fibrosis drugmaker could top $562 million Continue reading

Linden wins over SeraCare with $80.8M offer

The Chicago private equity firm pays about $4 per share for diagnostics company in its first take-private Continue reading

FDA issues key generic-drug guidelines

The draft outlines the approval process for biosimilars Continue reading

Arbs bullish on Roche-Illumina deal

The target's rejection of Roche's $5.4 billion offer prompts hopes of a bump in price. Continue reading

Roche wants talks after Illumina nixes bid

Roche professed itself "disappointed" by Illumina's rejection Continue reading

Antitrust jeopardy

Where divestitures and behavioral remedies are insufficient to resolve competitive concerns, the FTC and DOJ will not hesitate to litigate, regardless of the transaction's size or the clout that the parties may have on Capitol Hill Continue reading

Pfizer takes another step in restructuring

Pfizer Inc. took a step toward the long-awaited divestiture of its animal health business on Tuesday, Feb. 7, by agreeing to sell the India-based part of that division to another wholly owned unit the drugmaker is in the midst of... Continue reading

ProMedica pitches alternative to divestiture

The Ohio hospital operator that its acquired rival, St. Luke's Hospital in Toledo, is too weak to be spun off Continue reading

Meet the journalists

Ben Fidler

More Healthcare journalists: David Holley, Andrew Bulkeley

Aquila on the current state of dealmaking

Sullivan & Cromwell's Frank Aquila shares what he thinks are the leadi ... Video

More Healthcare video

The Deal Economy

Deal Economy 2012 was hosted at the New York Stock Exchange November 30 & December 1, 2011. Pipeline license holders have exclusive access to view on-demand all the panels and roundtables from our premiere dealmaking event.

Knowledge Centers

The Deal LLC's 2011 Webcast Series is a premier information source for professionals doing deals across the full spectrum of the deal economy. These six webcasts will present our audience with an in-depth perspective from leading dealmakers.

Careers

Jobs and Career Management in the Deal Community.

Featured job of the day: BBVA, Private Equity Fund of Fund Analyst

The Deal's city by city

Explore our expanding database of who's who in advisory, investing and lending in the American middle market. Together, through the big map, we can begin to get a comprehensive sweep of just who does the great bulk of dealmaking.